Epitomee Medical Stock Net Income
| EPIT Stock | 938.20 30.20 3.33% |
Epitomee Medical fundamentals help investors to digest information that contributes to Epitomee Medical's financial success or failures. It also enables traders to predict the movement of Epitomee Stock. The fundamental analysis module provides a way to measure Epitomee Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Epitomee Medical stock.
Epitomee |
Epitomee Medical Company Net Income Analysis
Epitomee Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Epitomee Medical reported net income of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The net income for all Israel stocks is 100.0% higher than that of the company.
Epitomee Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Epitomee Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Epitomee Medical could also be used in its relative valuation, which is a method of valuing Epitomee Medical by comparing valuation metrics of similar companies.Epitomee Medical is currently under evaluation in net income category among its peers.
Epitomee Fundamentals
| Current Valuation | 339.18 M | |||
| Shares Outstanding | 29.58 M | |||
| Shares Owned By Insiders | 56.83 % | |||
| Shares Owned By Institutions | 20.28 % | |||
| Price To Book | 3.48 X | |||
| Market Capitalization | 318.32 M |
About Epitomee Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Epitomee Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epitomee Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epitomee Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Epitomee Stock
Epitomee Medical financial ratios help investors to determine whether Epitomee Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epitomee with respect to the benefits of owning Epitomee Medical security.